HomeMedication lookupDrug classes › Statins
Statins

Statins and pharmacogenetics

Also known as: HMG-CoA reductase inhibitors, Cholesterol medications

7 medications 8 brand products SLCO1B1

Why pharmacogenetics matter for statins

Statins are the mainstay of cholesterol management and cardiovascular disease prevention. They share a class-wide pharmacogenetic story: the SLCO1B1 transporter moves statins from blood into liver cells where they work. People with reduced SLCO1B1 function accumulate statins in circulation (including in muscle), which directly drives statin-associated muscle pain (the single most common reason patients discontinue a statin).

SLCO1B1 testing is increasingly offered before or during statin therapy. Simvastatin is the most SLCO1B1-dependent; pravastatin and rosuvastatin are least affected. Switching within the class is often the simplest response to a positive SLCO1B1 result.

Key gene in this class

Medications in this class with pharmacogenetic guidelines

Each link goes to the drug's full pharmacogenetics page with CPIC and FDA phenotype recommendations.

Brand products in the Statins class

Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.

Which statins is right for your genetics?

This page covers the pharmacogenetics of statins in general. A Gene2Rx report tells you how your personal genotype interacts with every drug on this page.

Get your report Look up a medication

Informational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.

Get Your Report Now
Ready in One Minute